Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.

Abstract

HDR ILBT with metallic stenting for patients with obstructive jaundice from extrahepatic bile duct carcinoma appears to be feasible and associated with acceptable toxicity. These treatments may lead to an improved quality of life in these patients.